Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan for Skin Fibrosis in Systemic Sclerosis
NCT00318175Phase 2Completed
- Sponsor
- Heinrich Heine University Düsseldorf
- Start
- Jun 2006
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bosentan in systemic sclerosis (SSc), sponsored by Heinrich Heine University Düsseldorf. Primary endpoint: Reduction of skin thickening at 24 weeks. Started Jun 2006; status: completed.
02
Drugs
bosentan
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT00318175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00318175.